DIA 2013 49th Annual Meeting
Click here to go to the previous page
Quality Assurance for Signal Detection Programs
Track : Track 14: Clinical Safety and Pharmacovigilance
Program Code: 257
Date: Tuesday, June 25, 2013
Time: 1:45 PM to 3:15 PM  EST
Location: 152
CHAIR :
 Elizabeth E. Garrard, PharmD,RPh (SCHNON), Specialist Leader, Strategy Operations, Deloitte Consulting LLP, United States
SPEAKER (S):
 Kerstin Geldmeyer-Hilt, PhD (SPKNON), Dr. Ebeling & Assoc. Gmbh, Germany
Morell B. David, MSc (SPKNON), NDA Group, United Kingdom
George N. Pajovich, Pajovich, RPh (SPKNON), Head of Safety Risk Research, Pfizer Inc, United States
Description
New EU legislation requires quality assurance of critical safety processes, including signal detection. This forum will offer the chance to discuss how best to measure compliance, effectiveness, and efficiency of a signal detection program.